3rd Jun 2011 15:43
VERONA PHARMA plc ("Verona Pharma" or the "Company") RESULTS OF AGM
London, UK. Verona Pharma plc (AIM: VRP.L), the biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, announces that all resolutions proposed at the Annual General Meeting held today were duly passed.
For more information please contact:
Verona Pharma plc Tel: 020 7863 3300 Clive Page, Chairman [email protected] Michael Walker, CEO
Evolution Securities Limited (NOMAD and Joint Broker) Tel: 020 7071 4300 Bobbie Hilliam / Tim Redfern / Patrick Castle
[email protected] WH Ireland Group Plc (Joint Broker) Tel: 0121 265 6300 Richard Smith / Nicola Rayner [email protected] College Hill Tel: 020 7457 2020 Melanie Toyne Sewell / Gemma Howe [email protected]
vendorRelated Shares:
VRP.L